Pegasus Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-24,675
| Closed | -$1.9M | – | 73 |
|
|
2022
Q1 | $1.9M | Sell |
24,675
-142
| -0.6% | -$10.9K | 0.83% | 42 |
|
|
2021
Q4 | $2.19M | Buy |
24,817
+501
| +2% | +$44.3K | 0.9% | 38 |
|
|
2021
Q3 | $1.88M | Buy |
24,316
+1,633
| +7% | +$126K | 0.86% | 39 |
|
|
2021
Q2 | $1.89M | Buy |
22,683
+373
| +2% | +$31.1K | 0.88% | 40 |
|
|
2021
Q1 | $1.69M | Buy |
22,310
+2,138
| +11% | +$161K | 0.86% | 41 |
|
|
2020
Q4 | $1.77M | Buy |
20,172
+330
| +2% | +$28.9K | 0.97% | 36 |
|
|
2020
Q3 | $1.51M | Buy |
19,842
+774
| +4% | +$58.9K | 0.95% | 37 |
|
|
2020
Q2 | $2.35M | Sell |
19,068
-55
| -0.3% | -$6.78K | 1.61% | 28 |
|
|
2020
Q1 | $1.62M | Buy |
19,123
+222
| +1% | +$18.8K | 1.33% | 36 |
|
|
2019
Q4 | $1.6M | Buy |
+18,901
| New | +$1.6M | 1.05% | 39 |
|